Lead Editor - Newsgathering
ryan.bachoo@cnc3.co.tt
Cancer touches almost every family in Trinidad and Tobago, often quietly, sometimes suddenly, but always profoundly. Behind the statistics, screening campaigns and fundraising drives are individuals who have carried the responsibility of steering institutions through grief, hope, limited resources and growing public expectation. One such individual is Robert Dumas, former chairman of the Trinidad and Tobago Cancer Society, whose tenure coincided with an expanding national conversation about cancer prevention, patient support and the role of civil society in public health.
Dumas’ leadership was shaped not only by boardroom decisions and stakeholder negotiations, but by deeply personal experience. The loss of his father to cancer transformed advocacy from an abstract cause into a lived commitment, grounding his approach in empathy and human connection. During his time at the helm, the Society navigated persistent funding challenges, increasing demand for services, and longstanding structural issues such as the need for a permanent home, all while striving to keep patients and survivors at the centre of its work.
In this Q&A, Dumas reflects on his most significant contributions, the hardest challenges faced by the organisation, and how the cancer landscape has evolved locally. He also speaks candidly about gaps that remain in prevention, data collection and psychosocial support, and offers pointed advice to both current leadership and policymakers on moving from awareness to action.
Q: What do you consider your most significant contribution during your tenure as chairman of the T&T Cancer Society?
A: My most significant contribution during my tenure as Chairman of the Trinidad and Tobago Cancer Society has been helping to strengthen and humanise the Society’s relationships with all stakeholders, while keeping people at the centre of everything we do. I believe I made a meaningful impact through the relationships I built and nurtured with corporate partners, which helped expand collaboration, increase visibility for our initiatives, and strengthen support systems. The relationships I hold most dear, however, are those with cancer survivors and the communities we serve, whose resilience and trust continually remind me why this work matters.
My commitment to this work is deeply personal. Being touched by cancer through the loss of my father profoundly deepened my desire to make a difference and transformed advocacy into a calling. That experience fueled my determination to ensure that no one facing cancer feels alone, unheard, or without support, and to help foster a culture of empathy, compassion, and purpose within the Society.
What were the biggest challenges the organisation faced while you were at the helm, and how were they addressed?
Funding and financial sustainability have consistently been among the most significant challenges for the TTCS, as is the case for most NGOs. While the Society receives government subventions, these funds alone are not sufficient to meet the growing demand for programmes, patient support services, education, and operational costs. As a result, the TTCS has always depended heavily on fundraising initiatives and strong corporate collaborations to bridge the gap and sustain its work.
One of the most challenging areas, in my opinion, is particularly in relation to the Society’s need for a new home. Although the TTCS has been engaging the government for support toward this critical objective, progressing from advocacy to tangible outcomes has been slow and complex. Ensuring adequate physical space is essential for expanding services, improving patient experience, and strengthening operational capacity, and this remains a priority area requiring continued focus, partnership, and commitment.
How has the cancer landscape in Trinidad and Tobago changed over the years you were involved with the Society?
We certainly have seen an increase in overall awareness through an increased TTCS campaign of education, awareness and the need for early screening. Though actual data collection across both public and private sectors still remains a challenge, to date, the top cancers haven’t shifted dramatically in the years I served on the board, with breast and prostate cancers remaining the most commonly diagnosed overall, and colorectal and lung cancers continuing to be significant contributors to morbidity.
Were there any difficult decisions you had to make that the public may not fully understand?
None that I recall. A few changes in management occurred at Board level, but that was as a result of commitment challenges during any given period, as even though it is in a voluntary capacity, the portfolio is very demanding.
In your view, what gaps still exist in cancer prevention, treatment, and support services locally?
The T&T Cancer Society is not involved in treatment; that said, it was part of my long-term vision for the society to collaborate with other organisations to facilitate an end-to-end service. That said, prevention is still underpowered and under-prioritised. We do awareness; we don’t do enough intervention. Cancer education doesn’t meaningfully start early enough, nor is it integrated into long-term health literacy. Bottom line is, we are still reacting to cancer far more than we’re preventing it.
How important is public trust and transparency for organisations like the T&T Cancer Society, and how was that maintained during your leadership?
Receiving a government subvention, and corporate funding requires implementation and adherence to strict governance policies, and monitoring for short and long change of patient navigation mapping and subsequent systems to ensure best practices, efficiency, and ultimately the customer experience.
What advice would you give to the current leadership and to policymakers working to improve cancer care in Trinidad and Tobago?
To the T&T Cancer Society, it would be to keep focused on mission, but with that inclusivity of other NGOs, private institutions, and the regional health authourities is a must. The old African proverb, if you want to go fast, go alone, but if you want to go far, go together. The need for legislation to truly collate data in both private and public health institutions is critical to determining where focus is placed, with real-time, measurable data. Keep the people, both internal and external, top of mind with kindness, empathy and delivering 100 per cent each and every time.
To ALL involved in the drive, policy must treat the person, not just the disease. Psychosocial support, caregiver assistance, survivorship planning, and early palliative care should be embedded into standard care, not left to charity or chance. Prevention also needs to be elevated to a true national priority, woven into education, food policy, environmental regulation, and community life. The opportunity now is to move from expanding services to delivering excellence—a system that diagnoses earlier, treats more humanely, and supports people long after treatment ends.
